68 research outputs found
Π ΠΎΠ»Ρ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π’-ΠΈ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΠΈ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ Π»ΠΈΠΌΡΠΎΠΌ ΠΊΠΎΠΆΠΈ
The article presents the data on the studies contributing to improving the differential diagnostics of T-cell and B-cell
cutaneous lymphomas including large-plaque parapsoriasis and T-cell and B-cell cutaneous pseudolymphomas as well
as frequency of their transformation into malignant cutaneous lymphomas. There was a study of 101 patients using the
polymerase chain reaction method to determine the T-cell and B-cell lymphocyte clonality by genes of g and chains in
the T-cell receptor and immunoglobulin heavy chain genes. Monoclonality was determined in 40 of 46 cases in patients
with T-cell cutaneous lymphomas and in three of four cases in patients with B-cell cutaneous lymphomas. Monoclonality
was revealed in one of 14 cases of large-plaque parapsoriasis and one of two cases of T-cell cutaneous pseudolymphoma.
In all of the 24 cases of chronic benign dermatoses, five cases of small-plaque parapsoriasis and ten skin tissue samples
obtained from healthy donors, polyclonal lymphocytes were revealed. So, the obtained results make it possible to
consider the method to be an important addition in the field of diagnosing lymphoproliferative skin diseases.ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎΠ± ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΡΡΠΈΡ
ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ
Π’- ΠΈ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
Π»ΠΈΠΌΡΠΎΠΌ ΠΊΠΎΠΆΠΈ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Ρ ΠΊΡΡΠΏΠ½ΠΎΠ±Π»ΡΡΠ΅ΡΠ½ΡΠΌ ΠΏΠ°ΡΠ°ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ, Π’- ΠΈ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌΠΈ
ΠΏΡΠ΅Π²Π΄ΠΎΠ»ΠΈΠΌΡΠΎΠΌΠ°ΠΌΠΈ ΠΊΠΎΠΆΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎ ΡΠ°ΡΡΠΎΡΠ΅ ΠΈΡ
ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ Π² Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ Π»ΠΈΠΌΡΠΎΠΌΡ ΠΊΠΎΠΆΠΈ. Π£ 101 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°
ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ Ρ ΡΠ΅Π»ΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π’- ΠΈ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ
ΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² ΠΏΠΎ Π³Π΅Π½Π°ΠΌ g- ΠΈ -ΡΠ΅ΠΏΠ΅ΠΉ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ° ΠΈ Π³Π΅Π½Π°ΠΌ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΡΠ΅ΠΏΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π°.
Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌΠΈ Π»ΠΈΠΌΡΠΎΠΌΠ°ΠΌΠΈ ΠΊΠΎΠΆΠΈ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»Π°ΡΡ Π² 40 ΠΈΠ· 46 ΡΠ»ΡΡΠ°Π΅Π²,
Ρ Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌΠΈ Π»ΠΈΠΌΡΠΎΠΌΠ°ΠΌΠΈ ΠΊΠΎΠΆΠΈ - Π² 3 ΠΈΠ· 4 ΡΠ»ΡΡΠ°Π΅Π². Π’Π°ΠΊΠΆΠ΅ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΡ Π±ΡΠ»Π° Π²ΡΡΠ²Π»Π΅Π½Π° Π² 1 ΠΈΠ· 14 ΡΠ»ΡΡΠ°Π΅Π²
ΠΊΡΡΠΏΠ½ΠΎΠ±Π»ΡΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠ°ΡΠ°ΠΏΡΠΎΡΠΈΠ°Π·Π°ΠΌ ΠΈ Π² 1 ΠΈΠ· 2 ΡΠ»ΡΡΠ°Π΅Π² Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΏΡΠ΅Π²Π΄ΠΎΠ»ΠΈΠΌΡΠΎΠΌΡ ΠΊΠΎΠΆΠΈ. ΠΠΎ Π²ΡΠ΅Ρ
24 ΡΠ»ΡΡΠ°ΡΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄ΠΎΠ±ΡΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·ΠΎΠ², 5 ΡΠ»ΡΡΠ°ΡΡ
ΠΌΠ΅Π»ΠΊΠΎΠ±Π»ΡΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠ°ΡΠ°ΠΏΡΠΎΡΠΈΠ°Π·Π° ΠΈ 10 Π±ΠΈΠΎΠΏΡΠ°ΡΠ°Ρ
ΠΊΠΎΠΆΠΈ
ΠΎΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ½ΠΎΡΠΎΠ² Π±ΡΠ»Π° Π²ΡΡΠ²Π»Π΅Π½Π° ΠΏΠΎΠ»ΠΈΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΡ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ². Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ
ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΡΠΈΡΠ°ΡΡ Π΄Π°Π½Π½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ Π²Π°ΠΆΠ½ΡΠΌ Π΄ΠΎΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ΠΌ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π»ΠΈΠΌΡΠΎΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ
ΠΊΠΎΠΆΠΈ
Π‘ΠΠ£Π§ΠΠ Π£Π‘ΠΠΠ¨ΠΠΠΠ ΠΠ ΠΠΠΠΠΠΠΠ― Π€ΠΠ’ΠΠΠΠΠΠΠΠ§ΠΠ‘ΠΠΠΠ’ΠΠ ΠΠΠΠ Π² ΠΠΠ§ΠΠΠΠ ΠΠ ΠΠ―ΠΠΠΠΠΠ Π‘ΠΠ ΠΠΠΠ« ΠΠΠΠΠ¨ΠΠ½Π° ΠΠΠΠΠΠΠ Π§ΠΠΠΠ
The article describes a case of successful application of the photodynamic therapy for treatment of the classic type of Kaposis
sarcoma in the area of the glans of a 60-year-old patient.ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΎ ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΡΠ»ΡΡΠ°Ρ ΡΡΠΏΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΠΎΡΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΠΊΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠΏΠ°
ΡΠ°ΡΠΊΠΎΠΌΡ ΠΠ°ΠΏΠΎΡΠΈ Π² ΠΎΠ±Π»Π°ΡΡΠΈ Π³ΠΎΠ»ΠΎΠ²ΠΊΠΈ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ ΡΠ»Π΅Π½Π° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° 60 Π»Π΅Ρ
Relating the proton, neutron and deuteron structure functions in the covariant Bethe-Salpeter formalism
The neutron structure function F2n(x) is evaluated within the kinematic range
10**(-3)<x<1 from the deuteron and proton data by employing relativistic
theoretical description of F2D(x) and several assumptions on the hihg-x
asymptotics of F2n(x)/F2p(x). It is shown that new measurements of F2D(x) in
the range 0.6<x<0.8 would substantially improve understanding of the relation
between d and u valence quarks in the limit x -> 1.Comment: Revised on January 20, 2004: Modified Figs. 2 and 3 and the reference
lis
Evolution of the nucleon structure in the lightest nuclei
The evolution of the nucleon structure as a function of atomic mass A is
considered for the first time for the lightest nuclei, D, 3H, 3He and 4He, with
an approach based on the Bethe-Salpeter formalism. We show that the pattern of
the oscillation of the structure functions ratio r^A(x) = F_2^A/F_2^N(D) varies
with A by changing the position of the cross-over point x_3 in which r^A(x) =
1, unlike the pattern for nuclei with masses A larger than 4, where only the
amplitude of the oscillation changes. In particular we find that the pattern of
F_2(x) modifications is controlled with the values (1 - x_3) = 0.32 (D/N), 0.16
(3He/D) and 0.08 (4He/D). The obtained results follow from the relativistic
consideration of the nuclear structure and allow us to define a whole class of
modifications of the partonic distributions in the nucleon bound in a nucleus.
The EMC effect is explained as a particular case of the considered class.Comment: Preprint of the publication submitted to Physics Letters B. 12 pages
(LaTeX) including 3 encapsulated figure
ΠΠ€Π€ΠΠΠ’ΠΠΠΠΠ‘Π’Π¬ Π ΠΠΠ’ΠΠΠΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ― ΠΠΠΠ ΠΠΠΠΠΠΠΠ‘Π’Π¬ Π€ΠΠ’ΠΠ€ΠΠ ΠΠΠ ΠΠ Π ΠΠ’ΠΠΠΠ§ΠΠΠ ΠΠ ΠΠ‘ΠΠΠ ΠΠΠΠ‘ΠΠΠ ΠΠΠ¨ΠΠ
Lichen planus (LP) is an autoimmune disorder which is characterized by long lasting, recurrent course of a disease and by poor response to treatment (including systemic corticosteroids and cytostatics). Cutaneous and mucosal LP may present in atypical forms, several can transform to cancer with statistical confidence. Earlier, we have confirmed high clinical efficacy of photopheresis β method of adoptive immunotherapy in treatment of patients with typical LP.Target: research of clinical efficacy of photopheresis in complex trearment of atypical forms of cutaneous and mucosal LP.Materials and methods. There had been carried out a study of the clinical and immunological efficacy in two groups of patients: patients receiving complex therapy, which includes photopheresis with routine therapy (delagil, doxycycline and topical corticosteroids (I groupe β 23 patients) and receiving complex therapy, which includes photopheresis with single injection of methotrexate in dose of 10 mg with routine therapy ( II groupe β 18 patients).Results. In I group of patients immunological disorders were similar with results of earlier immunological studies in patients with lypical LP, among them increase in the number of CD16+-cells. In the II groupe immunological disorders were characterized by the rise of amount and activity of CD3+CD8+-lymphocytes. The high efficacy of Group I patient treatment was accompanied by the restoration of their tolerance to the skin antigenic structures, while maintaining the possibility for transendothelial migration of CD16 + cells. The effect of the treatment in Group II patients was also pronounced; however, due to the use of methotrexate, no normalization of the patientsβ immune parameters was observed.Conclusion. The data obtained confirms the high clinical efficacy of photopheresis in both groups of patients and its pathogenic validity in patients suffering from atypical lichen ruber planus.ΠΡΠ°ΡΠ½ΡΠΉ ΠΏΠ»ΠΎΡΠΊΠΈΠΉ Π»ΠΈΡΠ°ΠΉ (ΠΠΠ) β Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΊΠΎΠΆΠΈ ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ. ΠΠΠ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΡΡΡ ΠΊΠ°ΠΊ Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΡΠΉ Π΄Π΅ΡΠΌΠ°ΡΠΎΠ·, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠΈΠΉΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ, ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΈΡΡΡΡΠΈΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ, ΡΠ°ΡΡΠΎ ΡΠΎΡΠΏΠΈΠ΄Π½ΡΠΉ ΠΊ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΡΠΈΡΡΠ΅ΠΌΠ½ΡΠΌΠΈ ΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΈΠ΄Π°ΠΌΠΈ ΠΈ ΡΠΈΡΠΎΡΡΠ°ΡΠΈΠΊΠ°ΠΌΠΈ. ΠΡΠ΄Π΅Π»ΡΡΡ Π°ΡΠΈΠΏΠΈΡΠ½ΡΠ΅ ΡΠΎΡΠΌΡ ΠΠΠ ΠΊΠΎΠΆΠΈ ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ, Π½Π΅ΠΊΠΎΡΠΎΡΡΠ΅ ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
ΠΌΠΎΠ³ΡΡ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°ΡΡΡΡ Π² ΡΠ°ΠΊ ΡΠΎ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ. Π Π°Π½Π΅Π΅ Π½Π°ΠΌΠΈ Π±ΡΠ»Π° Π΄ΠΎΠΊΠ°Π·Π°Π½Π° Π²ΡΡΠΎΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΌΠ΅ΡΠΎΠ΄Π° Π°Π΄Π°ΠΏΡΠΈΠ²Π½ΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ β ΡΠΎΡΠΎΡΠ΅ΡΠ΅Π·Π° (Π€Π€) Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠΈΠΏΠΈΡΠ½ΡΠΌ ΠΠΠ.Π¦Π΅Π»Ρ: ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π€Π€ Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π°ΡΠΈΠΏΠΈΡΠ½ΠΎΠ³ΠΎ ΠΠΠ ΠΊΠΎΠΆΠΈ ΠΈ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π€Π€ Π² Π΄Π²ΡΡ
Π³ΡΡΠΏΠΏΠ°Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
: ΠΏΠΎΠ»ΡΡΠ°Π²ΡΠΈΡ
Π€Π€ Π½Π° ΡΠΎΠ½Π΅ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠΉ (Π΄Π΅Π»Π°Π³ΠΈΠ»ΠΎΠΌ, Π΄ΠΎΠΊΡΠΈΡΠΈΠΊΠ»ΠΈΠ½ΠΎΠΌ ΠΈ ΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΠΌΠΈ ΠΌΠ°Π·ΡΠΌΠΈ) ΡΠ΅ΡΠ°ΠΏΠΈΠΈ (I Π³ΡΡΠΏΠΏΠ° β 23 Π±ΠΎΠ»ΡΠ½ΡΡ
) ΠΈ Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ΅ Ρ ΠΎΠ΄Π½ΠΎΠΊΡΠ°ΡΠ½ΠΎΠΉ Π²Π½ΡΡΡΠΈΠΌΡΡΠ΅ΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ ΠΌΠ΅ΡΠΎΡΡΠ΅ΠΊΡΠ°ΡΠ° Π² Π΄ΠΎΠ·Π΅ 10 ΠΌΠ³ Π½Π° ΡΠΎΠ½Π΅ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ (II Π³ΡΡΠΏΠΏΠ° β 18 Π±ΠΎΠ»ΡΠ½ΡΡ
).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π I Π³ΡΡΠΏΠΏΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΠΈΠΌΠΌΡΠ½Π½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π±ΡΠ» ΡΡ
ΠΎΠ΄Π΅Π½ Ρ ΡΠ°Π½Π΅Π΅ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠΌΠΈ ΠΏΡΠΈ ΡΠΈΠΏΠΈΡΠ½ΠΎΠΌ ΠΠΠ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ CD16+-ΠΊΠ»Π΅ΡΠΎΠΊ. ΠΠΎ II Π³ΡΡΠΏΠΏΠ΅ ΠΈΠΌΠΌΡΠ½Π½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π»ΠΈΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎΠΌ ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ CD3+CD8+-Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ². ΠΡΡΠΎΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
I Π³ΡΡΠΏΠΏΡ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»Π°ΡΡ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠ»Π΅ΡΠ°Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΡΠΌ Π°Π½ΡΠΈΠ³Π΅Π½Π½ΡΠΌ ΡΡΡΡΠΊΡΡΡΠ°ΠΌ ΠΊΠΎΠΆΠΈ ΠΏΡΠΈ ΡΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π΄Π»Ρ ΡΡΠ°Π½ΡΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠΈΠ³ΡΠ°ΡΠΈΠΈ CD16+-ΠΊΠ»Π΅ΡΠΎΠΊ, Π²ΠΎ II Π³ΡΡΠΏΠΏΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΠΆΠ΅ Π±ΡΠ»ΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ, Π½ΠΎ Π½Π΅ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»ΠΎΡΡ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ ΠΈΠΌΠΌΡΠ½Π½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π²Π²ΠΈΠ΄Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅ΡΠΎΡΡΠ΅ΠΊΡΠ°ΡΠ°.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡ Π²ΡΡΠΎΠΊΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π€Π€ Π² ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏΠ°Ρ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ Π΅Π³ΠΎ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΡΡ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΠΎΡΡΡ ΠΏΡΠΈ Π°ΡΠΈΠΏΠΈΡΠ½ΠΎΠΌ ΠΠΠ ΠΊΠΎΠΆΠΈ
ΠΠ΅ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°ΡΡΡΠ° Π² ΡΠ»ΡΡΠ°ΡΡ Ρ Π²ΡΠΎΠΆΠ΄Π΅Π½Π½ΠΎΠΉ ΡΠΊΡΠΎΠΏΠΈΠ΅ΠΉ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ
The article presents data on the effects of ovarian hormones on the development of congenital cervical ectopia in young iparous women. Found that the pathological course of pregnancy leads to changes in the fetoplacental system, and results in a decrease of estriol concentration and increase of progesterone protective compensatory levels.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠΈ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ²ΡΡ
Π³ΠΎΡΠΌΠΎΠ½ΠΎΠ² Π½Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π²ΡΠΎΠΆΠ΄Π΅Π½Π½ΠΎΠΉ ΡΠΊΡΠΎΠΏΠΈΠΈ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ Ρ ΠΌΠΎΠ»ΠΎΠ΄ΡΡ
Π½Π΅ΡΠΎΠΆΠ°Π²ΡΠΈΡ
ΠΆΠ΅Π½ΡΠΈΠ½. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ, ΡΡΠΎ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΠΌ Π² ΡΠ΅ΡΠΎΠΏΠ»Π°ΡΠ΅Π½ΡΠ°ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΠ΅, ΠΏΡΠΎΡΠ²Π»ΡΡΡΠΈΠΌΡΡ Π² ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΡΡΡΠΈΠΎΠ»Π° ΠΈ Π·Π°ΡΠΈΡΠ½ΠΎ-ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΎΡΠ½ΠΎΠΌ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠΈ ΠΏΡΠΎΠ³Π΅ΡΡΠ΅ΡΠΎΠ½Π°
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π½Π°Π±Π»ΡΠ΄Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π’Π ΠΠΠΠΠΠ ΠΏΠΎ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΈΠΌΠΎΡΡΠΈ ΠΊΡΠ΅ΠΌΠ° Π’ΡΠ°Π²ΠΎΠ³Π΅Π½ ΠΈ ΠΊΡΠ΅ΠΌΠ° Π’ΡΠ°Π²ΠΎΠΊΠΎΡΡ
The article describes the results of the TRAMPLIN clinical multi-center follow-up prospective study for evaluating the efficacy, safety and tolerance of the Travogen cream (isoconazole) and Travocort cream (isoconazole, diflucortolone) in patients suffering from combined (allergic, mycotic, bacterial) skin lesions of different etiology and localization in Moscow.ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ³ΠΎ Π½Π°Π±Π»ΡΠ΄Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π’Π ΠΠΠΠΠΠ ΠΏΠΎ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΈΠΌΠΎΡΡΠΈ ΠΊΡΠ΅ΠΌΠ° Π’ΡΠ°Π²ΠΎΠ³Π΅Π½ (ΠΈΠ·ΠΎΠΊΠΎΠ½Π°Π·ΠΎΠ») ΠΈ ΠΊΡΠ΅ΠΌΠ° Π’ΡΠ°Π²ΠΎΠΊΠΎΡΡ (ΠΈΠ·ΠΎΠΊΠΎΠ½Π°Π·ΠΎΠ», Π΄ΠΈΡΠ»ΡΠΊΠΎΡΡΠΎΠ»ΠΎΠ½) Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ (Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ, ΠΌΠΈΠΊΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ, Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΠΌΠΈ) ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡΠΌΠΈ ΠΊΠΎΠΆΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠΉ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π² ΠΠΎΡΠΊΠ²Π΅
- β¦